ADHD medication and your heart, sleep, and weight - what we monitor

ADHD medication is generally safe when used under proper supervision. That last phrase does real work in the sentence. The supervision is not bureaucracy; it is the monitoring programme that catches the physiological effects of the medication before they become clinical problems. Three systems matter most: cardiovascular, sleep, and body weight. This article explains what we monitor, what the thresholds are, and what happens if something drifts.

Cardiovascular monitoring

Stimulants increase sympathetic nervous system activity. That produces three measurable effects in most patients:

Resting heart rate rises by 5 to 10 beats per minute on average.

Resting blood pressure rises by 2 to 5 mmHg systolic and 1 to 3 mmHg diastolic on average.

In a small minority, these changes are larger.

These numbers are clinically insignificant in a healthy adult. In an adult with pre-existing cardiovascular risk, or in an adult on higher doses, the numbers can become significant. Atomoxetine has similar effects. Guanfacine does the opposite and lowers blood pressure, with its own monitoring implications.

What we check and when

At the start of treatment we ask about a personal history of heart disease, arrhythmias, high blood pressure, stroke or TIA, unexplained fainting, and a family history of sudden cardiac death before age 40. For anyone with any of these, we may request a cardiology opinion before starting.

We measure your resting blood pressure and heart rate before your first dose, at each titration review, at each stable six-month review, and whenever you report a symptom that could be cardiovascular.

Thresholds that trigger action

Resting heart rate persistently above 100 beats per minute: we pause the medication, review, and usually reduce the dose.

Resting blood pressure persistently above 140/90 mmHg: same response.

Systolic blood pressure above 160 or diastolic above 100 at any review: same-day pause and investigation.

New chest pain, exercise intolerance, palpitations that feel unusual, unexplained fainting: stop medication, contact us, and we will arrange ECG and cardiology input as needed.

Do you need an ECG before starting?

NICE guidance does not mandate an ECG for every adult starting stimulant medication. We take an ECG if any of the following applies:

Personal history of cardiac disease or a relevant cardiac symptom.

Family history of sudden cardiac death, cardiomyopathy, or inherited arrhythmia.

Unexplained fainting episodes.

Over age 50 with any cardiovascular risk factors.

Baseline blood pressure or heart rate outside normal range.

If you would like a baseline ECG anyway for peace of mind, we can arrange one at our Westfield clinic.

Sleep

Stimulants can affect sleep in three ways:

Making it harder to fall asleep if the medication is still active at bedtime.

Making sleep lighter and more fragmented.

Paradoxically improving sleep for some patients whose pre-treatment ADHD-driven mental chatter was itself keeping them awake.

The sleep effect is highly individual and highly dose- and timing-dependent. We ask about sleep at every review.

Practical rules for sleep

Take lisdexamfetamine before 10am and atomoxetine in the morning or split morning-evening. Modified-release methylphenidate is best before noon. Immediate-release methylphenidate should not be taken after 2pm for most patients.

If your sleep has worsened since starting medication, we usually adjust the timing first, then the dose if that does not fix it.

Guanfacine typically improves sleep because of its sedating effect. It is taken at night.

Good sleep hygiene matters more on ADHD medication than off it. A regular wake time, daylight exposure within 30 minutes of waking, and avoidance of bright screens in the last hour before bed all help.

Body weight

Stimulants tend to reduce appetite, particularly during the hours the medication is active. Most patients lose between 1 and 4 kg in the first three months of treatment and then stabilise. For most people this is clinically insignificant; for some it is a welcome side effect; for a small minority it is a problem.

What we monitor

We record your weight at start of treatment, at each titration review, and at each stable review. We also ask about eating patterns: whether you are skipping meals, whether you feel faint or unwell from not eating, and whether your body composition has changed (muscle loss rather than fat loss).

Thresholds that trigger action

Weight loss greater than 5% of your starting body weight without your actively trying.

Eating less than two reasonable meals per day consistently.

Signs of under-nutrition: fatigue out of proportion to the medication, dizziness, cold intolerance, hair thinning, irregular periods.

The usual adjustments are to shift the dose timing (so there is a window in the day when your appetite returns), reduce the dose, or switch to a different drug.

What to do proactively

Eat a substantial breakfast before your medication reaches peak effect. High-protein food (eggs, yoghurt, beans on toast) stays with you longer than carbohydrate-heavy food.

Keep grazing foods available that do not require appetite to eat. Nuts, cheese, smoothies, protein bars.

Plan a proper evening meal for when your medication is wearing off and your appetite returns.

If you are losing weight you do not want to lose, tell us sooner rather than later. A small timing adjustment often fixes it.

What an annual review looks like

At your annual stable review we recheck blood pressure, heart rate, weight, and mood. We ask about sleep, appetite, and how the medication is holding up. We review whether the dose still feels right, whether there are any new side effects, and whether your circumstances have changed in a way that might warrant a different approach.

This review is included in your £149 monthly care subscription and in the bundled care plans. It is also a legal requirement for continuing controlled-drug prescribing, but the more important thing is that it is how we keep your treatment working safely for years rather than months.

The honest summary

Monitoring is not box-ticking. The heart rate check at three months has saved patients from unknown hypertension. The weight check at six months has caught patients who were quietly eating too little. The sleep question has redirected timing for hundreds of patients. If we do this well, you do not notice; your medication just keeps working.

Ready to start?

If this article has made you think it is time to find out, the next step is a short consultation with one of our ADHD-trained GPs.

Begin your consultation at this link. Online in 30 minutes, or in person at Westfield London.